Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study - Archive ouverte HAL Access content directly
Journal Articles Annals of Transplantation Year : 2022

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study

Bruno Roche
  • Function : Author
Artur Bauhofer
  • Function : Author
Miguel Ãngel Gomez Bravo
  • Function : Author
Georges Philippe Pageaux
  • Function : Author
Alejandra Otero
  • Function : Author
Martin Prieto
  • Function : Author
Carmen Baliellas
  • Function : Author
Didier Samuel
  • Function : Author

Dates and versions

hal-04013132 , version 1 (03-03-2023)

Identifiers

Cite

Bruno Roche, Artur Bauhofer, Miguel Ãngel Gomez Bravo, Georges Philippe Pageaux, Fabien Zoulim, et al.. Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study. Annals of Transplantation, 2022, 27, ⟨10.12659/AOT.936162⟩. ⟨hal-04013132⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More